HAVCR2 and B-cell chronic lymphocytic leukemia: As an additional mechanism that may affect NK antitumor activity in CLL, in line with data observed in conventional T cells, the immune checkpoint TIM-3 was found to be aberrantly expressed on the NK cell compartment of CLL patients and associated with poor prognostic factors [161].